PELVIC SOLITARY FIBROUS TUMOR, HISTORICALLY CLASSIFIED AS HEMANGIOPERICYTOMA, PRESENTING WITH VENOUS COMPRESSION AND PELVIC CONGESTION: A CASE REPORT
Abstract
Introduction: Solitary fibrous tumor is a rare fibroblastic mesenchymal neoplasm previously classified with hemangiopericytoma. Although it can occur at nearly any anatomical site, pelvic involvement is uncommon and symptoms usually appear late because they result from progressive mass effect.
Case presentation: A 69-year-old man presented with abdominal pain, progressive right lower limb swelling, and paresthesia. Laboratory findings showed mild anemia, elevated fibrinogen, and mildly increased C-reactive protein, while serum tumor markers remained normal. Multidetector computed tomography demonstrated a large lobulated hypervascular abdominopelvic mass with heterogeneous enhancement and central necrosis. Computed-tomographic angiography revealed compression of the right iliac vein, femoral venous dilatation, and marked pelvic venous congestion. Doppler ultrasonography confirmed abnormal venous flow without definite thrombosis.
Conclusion: (SFT) represents a rare but clinically significant diagnosis in the differential evaluation of large hypervascular pelvic masses. A multidisciplinary approach is essential for optimal treatment planning, while surgical resection remains the primary therapeutic modality.
References
1. Choi JH. Solitary fibrous tumor: an updated review. J Pathol Transl Med. 2026;60(1):20-46.
2. Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021;113(2):70-84.
3. Segami K, Okamura Y, Takahashi S, Ueda Y, Kanzaki K, Kudo Y. WHO Grade II or III Solitary Fibrous Tumors (Hemangiopericytomas) of the Spine: Two Case Reports with a Comprehensive Review of the Literature. Journal of Clinical Medicine [Internet]. 2025; 14(17):[6068 p.].
4. Denewar FA, Takeuchi M, Khedr D, Sherif FM, Shokeir FA, Urano M, et al. Solitary fibrous tumors from A to Z: a pictorial review with radiologic-pathologic correlation. Insights Imaging. 2025;16(1):112.
5. Kc S, Poudyal H. Solitary fibrous tumor of the Pelvic cavity: A rare entity with review of literature. Radiol Case Rep. 2024;19(10):4363-8.
6. Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, et al. Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers (Basel). 2023;15(24).
7. Tolstrup J, Loya A, Aggerholm-Pedersen N, Preisler L, Penninga L. Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review. Front Surg. 2024;11:1332421.
8. Tariq MU, Din NU, Abdul-Ghafar J, Park YK. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagn Pathol. 2021;16(1):32.
9. Di Prata C, Del Fiore P, Trevisiol C, Tropea S, Buzzaccarini MS, Krengli M, et al. Solitary fibrous tumour: histological discoveries, behavioural aspects, risk assessment and therapeutical approaches. Ther Adv Med Oncol. 2025;17:17588359251367320.
10. Akbulut M, Liffers ST, Mavroeidi IA, Falkenhorst J, Guder WK, Andreou D, et al. Solitary fibrous tumor: a retrospective analysis of clinicopathological characteristics and palliative treatment of 67 cases. ESMO Rare Cancers. 2025;3.
11. Hashimoto M, Hata T, Akashi H, Kato S, Morimoto Y, Nishizawa Y, et al. Complete Resection of a Giant Hypervascular Pelvic Floor Solitary Fibrous Tumor Using Intraoperative Balloon Occlusion and Staged Open Abdomen Management: A Case Report. Surg Case Rep. 2026;12(1).
12. Yan X, Zheng C, Wang J, Li D, Lu J, He L, et al. Transcatheter arterial embolization of malignant pelvic solitary fibrous tumor: case report and literature review. Transl Cancer Res. 2021;10(11):4979-87.
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).
